Simon Fraser University
Engaging the World

In preparation for its next round of funding, the RTO/ERO Foundation is seeking expressions of interest for projects that advance our collective knowledge about the impact of social isolation and loneliness on unpaid (family and friend) caregivers of seniors (65+) in Canada; and/or that evaluate innovative interventions to improve their social engagement and mental health.

National Institute of Allergy and Infectious Diseases (NIAID) and National Institute of General Medical Sciences (NIGMS) are issuing this Notice of Special Interest (NOSI) to highlight the urgent need for research on the 2019 novel Coronavirus (2019-nCoV). NIAID is particularly interested in projects focusing on viral natural history, pathogenicity, transmission, as well as projects developing medical countermeasures and suitable animal models for pre-clinical testing of vaccines and therapeutics against 2019-nCoV.NIGMS is specifically interested in incorporation of data from the 2019-nCoV into ongoing research efforts to develop predictive models for the spread of Coronaviruses and related pathogens.

This funding opportunity is a key component of the second phase of the Canadian Epigenetics, Environment and Health Research Consortium (CEEHRC); a multi-agency, pan-Canadian initiative led by CIHR. CEEHRC is Canada's contribution to the International Human Epigenome Consortium (IHEC). The national research consortium networks all of the funded CEEHRC components, and expands their reach to the broader health research community in Canada and internationally.

Recognizes individuals who have made profound contributions in Fundamental Physics, Life Sciences and Mathematics.

Roche Canada is committed to working in partnership with our Canadian community to develop solutions to the challenges of the COVID-19 pandemic.

The Yɑ:y̓əstəl Award (pronounced YA-YA STELL) will support teams in partnering with Indigenous communities in the Fraser region. These teams will plan research projects and carry out the pilot and feasibility-testing activities to inform future applications for more comprehensive patient-oriented research grants.

Recognizes remarkable individuals whose research or contributions to public policies supportive of research and development in Canada have achieved international recognition.

Honours champions in health research advocacy.

Innovations for Improving the Impact of Health Campaigns seeks innovative solutions that accelerate the improvement of coverage, reach, efficiency, and effectiveness of campaign-based delivery of health interventions. Initial grants of USD $100,000 will be awarded, and applications are only two pages, with no preliminary data required.

Bill and Melinda Gates Foundation seeks fundamentally transformative and innovative ideas to support the design and development of new MHH products that meet key criteria of being responsive to user needs - particularly in LMIC context; with priority focus on safety, unobtrusiveness, effectiveness (no leaking), cultural acceptability, and sustainability.

Bill and Melinda Gates Foundation invites proposals for interventions to address the following challenges related to the cesarean section: 1) Increasing access to cesarean section where it is currently inadequate, 2) Increasing quality and safety of cesarean section to reduce iatrogenic harm to both mothers and newborns and 3) Reducing rates of non-medically indicated cesarean section.

The Bill and Melinda Gates Foundation is committed to a long-term vision of expanding contraceptive options for the most vulnerable women in low-resource settings through development of new methods that better align with women’s preferences. Contraceptive product innovation will be required to achieve this goal. Specifically, the emphasis for this work is on developing safe and effective non-hormonal contraceptive agents with both improved overall tolerability and a side effect profile differentiated from hormonal methods.

The Rapid Response: Canada program was created to provide seed funding to catalyse novel, high-risk, high-reward translational research. The budget of the Rapid Response: Canada 2020 program has been increased to a maximum of $300,000 over up to 18 months.

The goal of the program is to provide funding for translational research that will accelerate the development of therapeutics for neurodegenerative diseases of aging.

Honours sustained excellence in Canadian health care and/or health care research.

For contributions to a field of basic or clinical research in one of the Institute's principal areas of research.

Funding program that supports future generation of Canadian researchers. The award consists of two parts (postdoc salary and operating grant) covering a period of three years, with no possibility for renewal.

The Strategy for Patient-Oriented Research (SPOR) is a national coalition of federal, provincial and territorial partners (patients and informal caregivers, provincial health authorities, academic health centres, charities, philanthropic organizations, private sector, etc.) dedicated to the integration of research into care.

This funding opportunity will support a Network to generate new knowledge to improve diagnosis and treatment of ME disease in Canada.

Rewards an individual who has promoted sound science and evidence on a matter of public interest.

The Fulbright Arctic Initiative creates a network to stimulate international scientific collaboration on Arctic issues while increasing mutual understanding among the people of the Arctic Council member states.  Using a collaborative model to translate theory into practice, program participants will spend 18 months engaged in addressing public policy research questions relevant to Arctic nations' shared challenges.

The University Publications Fund (UPF) is established under the authority of the Vice-President, Research for the purpose of providing support to faculty and staff of Simon Fraser University for their academic publications. Rapid Response Publications submissions are accepted year-round. Single and Serial Event Publication submissions are accepted annually: April 12th - May 13th.

The William and Ada Isabelle Steel Fund reflects the intent of the endowment left by William and Ada Isabelle Steel for research studies into any aspect of alcoholism and/or drug addiction. Submissions are accepted April 18 through May 18.

The focus of this intake is Single-Cell Omics, which includes single-cell genomics, epigenomics, transcriptomics, proteomics, proteogenomics, metabolomics, lipidomics, immunogenomics and bioinformatics, as well as the technologies enabling these single-cell omics approaches. Genome BC hopes to fund novel, innovative projects from a variety of sectors that will truly advance the field.This intake is open to proposals focused on any of the sectors supported by Genome BC: human health, forestry, fisheries and aquaculture, agriculture and agri-foods, mining, energy and environment.

The Stars Career Development award supports early-career/mid-career investigators in firmly establishing their careers in the area of arthritis research.

Recognizes substantial recent contributions in the biomedical sciences.

The Craig H. Neilsen Foundation is pleased to announce the launch of this year’s Psychosocial Research (PSR) grants cycle.

Recognizes individuals who have made, and are making, valuable contributions to cancer research and cancer control in Canada.

This funding opportunity supports new intervention research designed to mitigate the challenges experienced along the cancer survivorship journey, as well as the evaluation and validation of existing interventions to assess their potential for implementation as best practices.

Research funding to highly qualified graduate students and postdoctoral fellows across Canada through awards in Technology and Aging.

Release time awards for active Canadian scholars who have made a significant and remarkable contribution to their respective fields in the humanities, social sciences, natural sciences, health sciences or engineering.

The Rapid Response: Canada program was created to provide seed funding to catalyse novel, high-risk, high-reward translational research. The budget of the Rapid Response: Canada 2020 program has been increased to a maximum of $300,000 over up to 18 months.

The Research Project (R01) grant is an award made to support a discrete, specified, circumscribed project to be performed by the named investigator(s) in an area representing the investigator's specific interest and competencies, based on the mission of the NIH.Standard due dates for new applications are February 5, June 5, and October 5.

Recognizes outstanding contributions to medicine and the health sciences that have led to extraordinary improvements in human health.

A new initiative for launching big, audacious ideas.

Identifies and supports eminent women in science throughout the world.

Awarded to active (not retired) Canadian scholars who have made a substantial and significant contribution over a significant period to scholarly research.

The R21 grant mechanism is intended to encourage exploratory/developmental research by providing support for the early and conceptual stages of project development. Standard due dates are February 16, June 16, and October 16.

Recognizes the recent outstanding contributions of researchers to the global effort to fight neurodegenerative diseases of aging.

Under the umbrella of the Network of European Funding for Neuroscience Research (NEURON), a joint transnational call has been launched for multinational research projects on sensory disorders. Proposals should focus on impairment and/or loss of sensory function of neural origin. The proposals may include studies on sensory neurons, including receptor cells, the related neural pathways and connected brain areas.

The 'Network of European Funding for Neuroscience Research' (NEURON) was established under the ERA-NET scheme of the European Commission. The aim of ERA-NET NEURON is to coordinate and optimize research efforts and funding programmes of its partner countries in the fields of disease related neuroscience. CIHR and the NEURON funding organizations particularly wish to promote multi-disciplinary work and translational research proposals that combine basic and clinical approaches.

This program supports outstanding new investigators as they develop their careers as independent research scientists or clinician scientists to undertake high-quality cancer research, while in close collaboration and mentorship with established TFRI or CIHR-ICR-funded research teams

Recognizes and encourages world-class research and artistic creation, prizing contributions of lasting impact for their originality, theoretical significance and ability to push back the frontiers of the known world.

The MSFHR Innovation to Commercialization (I2C) Program provides funding support to help BC health researchers advance their products or technologies towards practical application to improve health outcomes, benefit society, and enrich the health innovation ecosystem in BC through contributing to talent development and a strong, sustainable knowledge economy.

Recognizes the efforts and achievements of pharmaceutical research and development.

The Strategy for Patient-Oriented Research (SPOR) is a national coalition of federal, provincial and territorial partners (patients and informal caregivers, provincial health authorities, academic health centres, charities, philanthropic organizations, private sector, etc.) dedicated to the integration of research into care.

Recognizes Canada’s leaders in sustainability for their contributions over the prior two years.

Provides funding to the very best postdoctoral applicants, both nationally and internationally, who will positively contribute to the country's economic, social and research-based growth.

The Research Project (R01) grant is an award made to support a discrete, specified, circumscribed project to be performed by the named investigator(s) in an area representing the investigator's specific interest and competencies, based on the mission of the NIH.Standard due dates for new applications are February 5, June 5, and October 5.

The EU Joint Programme - Neurodegenerative Disease Research (JPND) was established to better coordinate research efforts across countries and disciplines to find causes, develop cures, and identify better ways to care for people with neurodegenerative diseases more rapidly. The goal of this joint transnational call is to promote research aiming at the development of novel and the advanced use of existing cutting-edge imaging and brain stimulation technologies related to neurodegenerative diseases.

This funding opportunity supports the creation of six network in the areas of musculoskeletal (MSK) rehabilitation, muscular dystrophy, skin health, concussion and youth mental health.

Recognizes those with a demonstrated track record in research with excellence in scientific rigor, innovative thinking, imagination and originality.

This funding opportunity is to support innovative research projects to seek new knowledge (or accelerate the application of existing knowledge) that can improve the efficient and appropriate utilization of blood products while maintaining the safety of the blood system.

The R21 grant mechanism is intended to encourage exploratory/developmental research by providing support for the early and conceptual stages of project development. Standard due dates are February 16, June 16, and October 16.

The MSFHR Health Professional-Investigator (HP-I) Program is designed to help close the gap between health research and its implementation by supporting health professionals who are actively involved in patient care to conduct and apply research relevant to health and/or the health system.

Recognizes distinguished Chinese Canadians who have made outstanding professional achievements.

The Rapid Response: Canada program was created to provide seed funding to catalyse novel, high-risk, high-reward translational research. The budget of the Rapid Response: Canada 2020 program has been increased to a maximum of $300,000 over up to 18 months.

The goal of the program is to provide funding for translational research that will accelerate the development of therapeutics for neurodegenerative diseases of aging.

The goal of the CIHR-ICRH/CAAIF/AZ Canada/AllerGen Emerging Researcher Awards in Allergic Asthma is to enable Canadian allergists, clinical immunologists, MD clinician scientists, and basic scientists working in translational research to pursue academic research in allergic asthma.

This call aims to support innovative and cutting-edge interdisciplinary artificial intelligence (AI) research that encourages the exploration of new interdisciplinary research methodologies, approaches and tools in social sciences and humanities, health and biomedical sciences, and natural sciences and engineering.

This funding opportunity supports the development and testing of innovative methodologies/designs of innovative clinical trials (iCT) that is integrated with the principles of Strategy for Patient-Oriented Research (SPOR).

This catalyst grant supports research to expand current evidence and understanding of disease prevention that will lead to future intervention studies.

Rewards recent discoveries of particular originality and importance to basic medical research.

Genome BC is launching a COVID-19 Rapid Response Funding Initiative to fund promising research and innovation projects that have the realistic potential to have a quick and material impact on evolving COVID-19 related challenges. This program will be conducted as a rolling intake starting March 30, 2020.

This opportunity is to support the establishment of a multidisciplinary platform with the research expertise to identify best practices for studying sex and age as biological variables in basic science, provide training, and promote these methods and services.

The purpose of this RFP is to solicit proposals to complete one environmental scan, a comprehensive literature review, and a knowledge synthesis and options paper that focus on respite services and support for families of CYSN (children and youth with special needs) in order to provide evidence-based advice that will support better, less fragmented services to families of CYSN in BC.

Empowers young researchers to lead International, interdisciplinary, and intergenerational dialogue with the goal to make global decision making evidence-based and inclusive.

Stimulates fundamental research by early-career scientists and scholars of outstanding promise.

Recognizes renowned scientists and artists for their achievements for humanity and for friendly relations between people.

Honours those who have contributed significantly to the scientific, cultural, and spiritual betterment of mankind.

The Rapid Response: Canada program was created to provide seed funding to catalyse novel, high-risk, high-reward translational research. The budget of the Rapid Response: Canada 2020 program has been increased to a maximum of $300,000 over up to 18 months.

The goal of the program is to provide funding for translational research that will accelerate the development of therapeutics for neurodegenerative diseases of aging.

C2 awards support teams of health researchers and research users planning and carrying out collaborative activities such as stakeholder consultations, public engagement or co-development of research methodologies.

The MSFHR Reach Program provides funding to support the dissemination and uptake of research evidence to inform and improve further research, practice and policy-making.

Recognizes outstanding achievements in biomedical research for the benefit of human health.

A self-governing Fellowship made up of the most eminent scientists, engineers and technologists from the UK and the Commonwealth.

Aims to provide fresh impetus to first-class research and development in the 21st century, to bring about positive change to the global community, and to create a brighter future for all humanity.

Recognizes breakthroughs in pure or applied life science research.

Recognizes the world's top scientists who have made outstanding achievements in Global Health Research.

Recognizes outstanding biomedical scientists who have made original contributions to medicine.

Recognizes exceptional leadership in Canadian medical science.

Griffith University and Simon Fraser University Collaborative Travel Grant's are awarded for the purpose of expanding cooperation, exchange ideas and research collaborations between our two institutions in the following areas: Drug discovery; Environmental sciences and environmental planning; Forest ecology, forest management and climate change adaptation; Behavioural and cognitive neuroscience; Mental health and addiction; Public health; Bioinformatics and genomics; Big Data; Criminology; Business; Tourism Musicology.

The Research Project (R01) grant is an award made to support a discrete, specified, circumscribed project to be performed by the named investigator(s) in an area representing the investigator's specific interest and competencies, based on the mission of the NIH.Standard due dates for new applications are February 5, June 5, and October 5.

National Heart, Lung, and Blood Institute (NHLBI) is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for research on Coronavirus Disease 2019 (COVID-19) and on biological effects of its causative agent, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Topics of specific interest to NHLBI include host response, associations with heart, lung, and blood (HLB) diseases, potential impacts on transfusion safety, and clinical outcomes of infected individuals.

This opportunity is to support the establishment of a multidisciplinary platform with the research expertise to identify best practices for studying sex and age as biological variables in basic science, provide training, and promote these methods and services.

The field of sex and gender science aims to deepen our understanding of how biological and social influences interact to affect health and disease.

Honours excellence in health research and its translation into benefits for Canadians. These prizes, worth $100,000, are awarded every two years (with competitions closing in even-numbered years). These are institutional nominations;

Rewards outstanding achievement in the fields of: Biochemistry and Biophysics, Cognitive Science, Environmental Sciences, History, and Medicine

The R21 grant mechanism is intended to encourage exploratory/developmental research by providing support for the early and conceptual stages of project development. Standard due dates are February 16, June 16, and October 16.

The CIHR HIV/AIDS Community-Based Research (CBR) Program is one of four research funding areas of the CIHR HIV/AIDS Research Initiative. The CIHR HIV/AIDS Research Initiative is responsible for the research components of the major Government of Canada initiative in HIV/AIDS, namely the Federal Initiative to Address HIV/AIDS in Canada (FI).

The aim of the Catalyst Grant component of the CBR program is to provide seed money to support HIV/AIDS CBR research activities which represent a first step towards the pursuit of more comprehensive funding opportunities (e.g., operating grants).

Genome BC’s Sector Innovation Program has launched a new intake – Intake 6 (SIP6), focusing on environmental DNA (eDNA). This competition aims to support genomics research which will address gaps in eDNA analyses that pose barriers to extract and utilize environmental information.

Recognizes the world’s most foremost scientists, physicians and researchers for their breakthroughs in bio-medicine.

The Research Project (R01) grant is an award made to support a discrete, specified, circumscribed project to be performed by the named investigator(s) in an area representing the investigator's specific interest and competencies, based on the mission of the NIH.Standard due dates for new applications are February 5, June 5, and October 5.

Traditional Fulbright awards are open to Canadian scholars in all fields and are designed to enable emerging and established scholars, post-doctoral researchers and experienced professionals to conduct research, teach, or undertake a combination of both activities for one semester or a full academic year at any university or research center of their choice in the United States.

Recognizes exceptional contributions in the area of population and public health research.

The R21 grant mechanism is intended to encourage exploratory/developmental research by providing support for the early and conceptual stages of project development. Standard due dates are February 16, June 16, and October 16.

Honours individuals that have distinguished themselves by making a significant and lasting contribution to the world of innovation.

Recognizes a promising Early Career Scientist and an outstanding Senior Scientist’s contributions to science.

Recognizes current or recent innovations that have a positive impact on the quality of life in Canada.

Recognizes and encourages innovative and interdisciplinary research that cuts across traditional boundaries and paradigms.

Honours individuals who have recently achieved significant breakthrough in academic and scientific research or applications.

Recognizes remarkable contributions in the arts, the humanities and the sciences, as well as in Canadian public life.

Recognizes scientists for pioneering advances in our understanding of existence at its biggest, smallest, and most complex scales. 

Recognizes the emerging generation of Canadian intellectual leadership.

Recognizes and supports researchers who are already having a profound impact on the health and well-being of their fellow citizens.

Recognizes and encourages scientific and technological research and development.

Honours individuals in the fields of Cosmology, Genetics, and Neuroscience, whose groundbreaking work provides new models that inspire and enable fundamental shifts in knowledge and culture.

Recognizes contributions to the understanding of vision loss.

Recognizes outstanding achievement, dedication to the community and service to the nation.

Engages the broad public in informed discourse on matters related but not limited to health research and health research policy.

Promotes originality and excellence of research in the field of Biophysics.

Celebrates British Columbians who go above and beyond in their dedication and service to others and who devote time and energy to making their communities more caring, dynamic, beautiful, healthy, and unique.

Rewards excellence by recognizing breakthroughs in science and technology.

Honours extraordinary women leaders.

In preparation for its next round of funding, the RTO/ERO Foundation is seeking expressions of interest for projects that advance our collective knowledge about the impact of social isolation and loneliness on unpaid (family and friend) caregivers of seniors (65+) in Canada; and/or that evaluate innovative interventions to improve their social engagement and mental health.

Recognizes researchers in the area of psychiatry who are making an outstanding contribution in the field.

For outstanding achievements in research of any branch of science.

Recognizes the importance and significance of research within the biomedical and natural sciences, technology, engineering and mathematics domains.

Recognizes a British Columbian clinician scientist whose work in health research is internationally recognized and has had a significant impact on advancing research in his or her field.

Awards service to humanity in the fields of physics, chemistry, physiology or medicine, literature, and peace.

Recognizes remarkable achievements that are contributing to world civilization.

Recognizes excellence in Canadian innovation and entrepreneurship, while educating present and future generations of disruptors.

Celebrates and honours those in our B.C. community who successfully position our province as a competitive global cluster in the life sciences sector.

Recognizes outstanding contributions to the treatment, amelioration, or cure of brain disorders.

For contribution to community beyond academy.

Recognizes the contributions of scientists, physicians, and public servants who have made major advances in the understanding, diagnosis, treatment, and prevention of human disease.

The MSFHR Scholar Program allows early-career researchers to establish an independent research career, build a leading research program, and expand their potential to make significant contributions to their field.

The focus of this intake is Single-Cell Omics, which includes single-cell genomics, epigenomics, transcriptomics, proteomics, proteogenomics, metabolomics, lipidomics, immunogenomics and bioinformatics, as well as the technologies enabling these single-cell omics approaches. Genome BC hopes to fund novel, innovative projects from a variety of sectors that will truly advance the field.This intake is open to proposals focused on any of the sectors supported by Genome BC: human health, forestry, fisheries and aquaculture, agriculture and agri-foods, mining, energy and environment.

The R21 grant mechanism is intended to encourage exploratory/developmental research by providing support for the early and conceptual stages of project development. Standard due dates are February 16, June 16, and October 16.

Recognizes an outstanding contribution to health services and policy research, policy and/or care delivery in Canada.

Recognizes contributions to the theoretical foundations of human cognition.

Recognizes a Canadian physician or scientist who makes outstanding contributions to the treatment, amelioration, or development of therapies for cancer.

Recognizes significant contributions to the advancement of science and technology.

Recognizes outstanding contributions to the treatment, amelioration, or cure of heart disorders.

Honours and supports those offering practical and exemplary answers to the most urgent challenges facing us today.

Rewards outstanding scholarship and research in various fields.

Recognizes an important publication in the history of medicine.

Awards outstanding scientific contributions of individuals from all scholarly disciplines aiming at improving the development and living conditions of children and youth.

Recognizes excellence in medical science.

Recognizes the outstanding and creative achievements of researchers in the fields of medicine and life sciences, in particular those contributing to scientific developments in medicine.

This round of funding will focus on antimicrobial resistance in the environment. Funding available is $1 million per year for four years.

The Research Project (R01) grant is an award made to support a discrete, specified, circumscribed project to be performed by the named investigator(s) in an area representing the investigator's specific interest and competencies, based on the mission of the NIH.Standard due dates for new applications are February 5, June 5, and October 5.

Any British Columbian (or former long-term resident) who has demonstrated outstanding achievement, excellence or distinction in any field. Community leadership, business, labour, industry, volunteer service, research, culture, the arts, sports… the possibilities are nearly endless.

Recognizes contributions to the promotion of health science.

Honours scientists who have made significant contributions in Paul Ehrlich's field of research, in particular immunology, cancer research, microbiology, and chemotherapy.

Fosters culture, the sciences and the most meritorious initiatives in the cause of humanity, peace and fraternity among peoples throughout the world. 

Honours outstanding research in the field of circulatory diseases by a scientific investigator or group of investigators.

Recognizes excellence in astronomy and mathematics, biosciences, geosciences or polyarthritis research.

Genome BC is launching a COVID-19 Rapid Response Funding Initiative to fund promising research and innovation projects that have the realistic potential to have a quick and material impact on evolving COVID-19 related challenges. This program will be conducted as a rolling intake starting March 30, 2020.

Recognizes outstanding works in five categories: Service to Islam, Islamic Studies, Arabic Language and Literature, Medicine, and Science.

The Project Grant Program is designed to capture ideas with the greatest potential to advance health-related fundamental or applied knowledge, health research, health care, health systems, and/or health outcomes.

Recognizes scientific contributions relating to tobacco consumption and disease.

The Planning Award will support teams in partnering with patients and other stakeholders to plan research studies or knowledge translation (KT) projects (knowledge dissemination or implementation) in the Fraser region.

NIDA is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for research on the 2019 Novel Coronavirus (2019-nCoV, also known as COVID-19). NIDA is especially interested in research collecting and examining data on the risks and outcomes for COVID-19 infection in individuals suffering from substance use disorders.

CIFAR has announced a targeted call for AI and COVID-19 interdisciplinary research collaborations to spark innovative, high-risk/high-reward ideas and projects. The AI and COVID-19 Catalyst Grants will provide funding for up to $15,000 for successful applicants. Deadline to submit a proposal is April 3, 2020, 11:59 EDT. Kindly see funding opportunity for further details.

The Grand Challenges family of initiatives fosters innovation to solve key health and development problems.

C2 awards support teams of health researchers and research users planning and carrying out collaborative activities such as stakeholder consultations, public engagement or co-development of research methodologies.

Recognizes an outstanding contribution to the practice of medicinal chemistry or to an outstanding example of new drug discovery.

To improve the treatment, quality of life, and long-term outlook for children with brain tumors through research, support, education, and advocacy.

An Investigator Award supports individuals who are 4‐10 years into their careers as investigators and have made outstanding contributions and demonstrated leadership in arthritis research.

These grants provide support for meetings that promote the development of new research teams, for grant planning specifically for arthritis

Provides one-time funding to catalyze research in models of care in preparation for larger scale competitions to be offered by the Society and other funding agencies.

Funding to support research proposals aligned with the Society’s priorities.

To assist young investigators with laboratory start up costs. These grants can be combined with institutional, provincial or other eligible matching funds to purchase major equipment.

Intended to provide junior academics within 4 years of a full time research appointment, with what would usually be their first opportunity to demonstrate their ability to initiate and carry out independent research of relevance to arthritis.

The Alliance for Accelerating Excellence in Science in Africa (AESA), an initiative of the African Academy of Sciences and the New Partnership for African Development (NEPAD), in partnership with the Bill & Melinda Gates Foundation has launched two requests for proposals for Grand Challenges Africa - Innovation Seed Grants

A Brain Tumour Research Fellowship encourages and enables young clinicians and scientists to enter the field of brain tumour research and will accelerate studies leading to a cure for brain tumours.

CCS-Partner Prevention Research Grants have been created to support investigators who approach research in key prevention and risk reduction areas.

To encourage research projects that will close the gap between what is known from research and what is done with that knowledge in the health care community and public health practice.

To support and accelerate research and the application of new knowledge with imminent application potential relevant to cancer prevention in human populations.

This program funds innovative pilot research so that scientists can test their initial ideas and generate preliminary data used to qualify for larger, more sustained grants from other organizations.

The mission of the OCRP is to support patient-centered research to prevent, detect, treat, and cure ovarian cancer.

The mission of the OCRP is to support patient-centered research to prevent, detect, treat, and cure ovarian cancer.

The overarching goal of the Ovarian Cancer Academy is to develop successful, highly productive ovarian cancer researchers in a collaborative research and career development environment.

To support patient-centered research to prevent, detect, treat, and cure ovarian cancer. Currently no program funding opportunities are open.

By coupling research and innovation, Horizon 2020 emphasizes excellent science, industrial leadership and tackling societal challenges. The goal is to ensure Europe produces world-class science, removes barriers to innovation and makes it easier for the public and private sectors to work together in delivering innovation.

The programme supports research and study visits up to three months within the framework of the bilateral exchange of scientists and scholars.

Supports eligible recipients to pursue targeted R&D partnerships with key foreign organizations that may lead to the commercialization of Canadian technologies.

Grand Challenges Canada seeks bold ideas for products, services and implementation models that could transform how persistent challenges in reproductive, maternal, newborn and child health are addressed in low- and middle-income countries.

Funding for investigation and support of complementary and alternative medicine and for economic education that promotes the principles of a free market.

The objectives of the IC-IMPACTS Innovation Demonstration Initiative are to encourage the transfer of technology and knowledge resulting from India-Canada research and technology development partnerships, foster Canada-India collaborative research and trade development activities, demonstrate the effectiveness of innovative technologies for the Canadian and Indian marketplace, and improve the health, safety and prosperity of communities through the introduction of new technologies in Canada and/or India and to improve Canada-India economic ties.

A variety of targeted research grants related to understanding and curing diabetes, launched on an ongoing basis.

The Canadian Lung Association funds research and research training at the national level, offering several competitions for research funding.

The mission of the March of Dimes is to improve the health of babies by preventing birth defects, premature birth and infant mortality.

To initiate interdisciplinary discussions on problems or issues, to help launch interdisciplinary research networks, or to fund communities of researchers/practitioners dedicated to developing new methods, tools, and applications of basic research to applied problems.

Build research partnerships while funding your grad students and postdocs. Apply any time for flexible funding.

A pilot program to grow small to medium enterprises and other companies in Canada by connecting them with multinational sponsor companies and talented researchers at Canadian universities to collaborate on industrial research challenges of mutual interest.

This program supports graduate student research in a 16 to 24 week research project with an international industry partner located in any country except the United States.

The Mitacs Globalink Research Award funds research collaborations between senior undergraduate and graduate students and faculty members at a university overseas, including newly added destinations.

NIH offers funding for many types of grants and contracts.

The US National Science Foundation funds research and education in most fields of science and engineering.

Prostate Cancer Canada offers a limited number of Discovery Grants. While supporting novel research that aims to open up new lines of investigation, the goal is to support new and innovative studies in prostate cancer research.

Prostate Cancer Canada invites applications for investigator-initiated Movember Translation Acceleration Grants that address a significant issue in the management of prostate cancer. Proposals should leverage existing knowledge and capabilities to accelerate impact without overlapping currently funded Prostate Cancer Canada and Movember initiatives.

The mission of the Simons Foundation Autism Research Initiative is to improve the understanding, diagnosis and treatment of autism spectrum disorders by funding innovative research of the highest quality and relevance.

Aimed at researchers who want to host their own scientific event in Switzerland, invite colleagues from abroad for a research visit to Switzerland, or visit their colleagues in another country.

Research grants for children's medical research.

Small grants

Awarding educational and research grants to recipients who have become the world’s leading scientists and voice clinicians.

This award would be suitable for spending a sabbatical year in Germany. An academic in Germany with whom you would collaborate during your sabbatical could nominate you for this award.

Grants to outstanding Canadian charitable organizations offering unique and inspiring programs or projects for the benefit, improvement and development of Canadian society.

To carry out long-term research (6-24 months) in Germany. Applicants choose their own topic of research and their academic host.

To sponsor a 6 to 18 month research stay at a research institution in Germany. The fellowship is flexible and can be divided up into as many as three stays within three years.

Scientists and scholars from all non-European countries, who completed their doctorates less than 18 years ago, who are internationally recognized for their achievements in the field of applied research, and who in future are expected to continue producing cutting-edge achievements which will have a seminal influence on their discipline beyond their immediate field of work, are eligible to be nominated for a Fraunhofer-Bessel Research Award.

Academics of all disciplines from abroad, who are internationally recognized as leaders in their field and who are expected to contribute to enhancing Germany's sustained international competitiveness as a research location in consequence of the award, are eligible to be nominated for an Alexander von Humboldt Professorship.

Granted in recognition of a researcher's entire achievements to date, to academics whose fundamental discoveries, new theories, or insights have had a significant impact on their own discipline and who are expected to continue producing cutting-edge achievements in the future.

Excellent scientists and scholars of all nationalities who are expected to continue producing outstanding academic achievements in international collaboration are eligible to be nominated for the Max Planck Research Award.

The Konrad Adenauer Research Award honors researchers from Canada whose fundamental discoveries, new theories, or insights have had a significant impact on their own discipline and beyond.

To explore key questions of global importance that can best be addressed through interdisciplinary, international teams.

The Canadian Glycomics Network (GlycoNet) is a Network of Centres of Excellence that focuses on the role of glycans (carbohydrates) in health. Areas of focus for GlycoNet in Cycle II (2020–23) are antimicrobials, chronic diseases (including diabetes & obesity), neurodegenerative diseases, and cancer.

To support innovative, creative problem solving in cancer research.

A special initiative to allow junior investigators in cancer research to gain knowledge and understanding of the Canadian Cancer Society Research Institute peer-review process.

Focused on increasing Canada’s capacity for breast cancer prevention research. Recently appointed Assistant Postdoctoral and clinical fellows and junior faculty in the field of breast cancer, breast health, and cancer prevention are encouraged to apply.

Stipends for conducting prostate cancer research.

To support innovative, creative problem solving in cancer research.

The Project Grant Program is designed to capture ideas with the greatest potential to advance health-related fundamental or applied knowledge, health research, health care, health systems, and/or health outcomes.

To provide funding support for clinical trials and clinical trial sub-studies that have excellent preliminary data, targeting neurodegenerative diseases of aging.

Designed for those very few instances when an exceptional research opportunity would be missed if a project had to wait to undergo the normal course of a national competition before a decision could be rendered.

Celebrates the contributions of individuals who have had a remarkable impact on cancer research and the cancer research community.

Weston Brain Institute has launched a new "Big Ideas" funding program to support large scale research projects that have a significant and sustained impact on accelerating translational research on the development of therapeutics for neurodegenerative diseases of aging.

MSFHR offers match funding to qualifying BC-based researchers and research teams who are applying to non-BC government-funded research competitions that require applicants to source match funding as a condition of the application.

This Request for Applications (RFA) is designated for research to advance methods to restore, replace or provide reliable gastrointestinal and/or urodynamic function following SCI.

The Translational Research Partnership Program supports collaborative projects in cancer research to help accelerate the development of new treatments and/or technologies for the benefit of patients.

VPR Major Research Project Application Preparation grants assist SFU faculty members who are applying for major external research grants (e.g., CFI, NCE or SSHRC MCRI or INE). Assistance may take the form of support salaries for personnel needed to prepare application materials, costs of travel required to meet with research collaborators, long-distance telephone/fax charges, etc. These grants do not fund research per se.

AstraZeneca Canada’s Corporate Giving Program seeks to improve the health and quality of life of Canadians. The company supports projects and initiatives that improve healthcare in the company's local communities, promote science education and skills among young people, support chronic disease prevention programs for adolescents, or are connected to the giving and volunteer activities of company employees.

The Canadian Hemophilia Society invites applicants to apply for basic scientific research grants in fields relevant to hemophilia A and B, von Willebrand disease, rare factor deficiencies, platelet function disorders (and platelet pathophysiology) and other congenital and acquired bleeding disorders.

The Early Phase Clinical Trials: Canada program was created to provide funding support for clinical trials and clinical trial sub-studies with excellent preliminary data.

Mizutani Foundation for Glycoscience is a non-profit organization established on October 1, 1992 with funds donated by the late Mr. Masakane Mizutani, former Emeritus Chairman of Seikagaku Corporation, Tokyo, Japan. The objective of the Foundation is to promote world-wide progress in glycoscience.

The objective of the International stream is to support international research collaborations and position Canada and Canadian researchers as strategic partners at the international level. The New Frontiers in Research Fund (NFRF) 2020 Horizon Global Platform competition provides funding for Canadian researchers who are partners on successful projects funded through eligible calls under the EU Horizon 2020.

IC-IMPACTS is seeking project proposals in the deployment-ready stage of development related to IC-IMPACTS three themes on safe and sustainable infrastructure, integrated water management and public health and disease prevention.

National Center for Advancing Translational Sciences (NCATS) is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for research on the 2019 novel Coronavirus (COVID-19). NCATS is particularly interested in projects focusing on the use of informatics solutions to diagnose cases and the use of CTSA-supported core resources (e.g., advanced scientific instruments, highly-specialized facilities, and regulatory expertise) to facilitate research on COVID-19 and advance the translation of research findings into diagnostics, therapeutics, and vaccines. NCATS is soliciting applications for Administrative Supplements to UL1, U01, and R21 awards (through PA-18-591), Collaborative Innovation Awards to U01 and R21 awards (through PAR-19-099 and PAR-19-100, respectively), and Competitive Revisions for UL1 awards for each of the non-administrative supplement awards (through PAR-19-337).

This program will build teams to address challenges requiring further research and development for solutions to meet COVID-19 related needs. The NRC will build these teams drawing on internal-to-government capacity and academic researchers who register to indicate their interest, and related areas of expertise and capabilities.

Please see the following important call for project ideas or proposals from Canada's Digital Technology Supercluster for COVID-19 related-research. Further information and questions can be directed to Avi Kapoor, Strategic Partnerships Manager for SFU's Big Data Initiative.